24 C
New York
Wednesday, June 3, 2026

Tag: Cardiff

newssourceFORcompanyinformationcontent1marketreleases

Kazia Therapeutics Appoints James Levine as Chief Financial Officer

SYDNEY, June 2, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia," "Kazia Therapeutics" or the "Company"), a clinical-stage oncology company advancing therapies designed...

Dark Horse CPAs Announce Hiring of Joey Kinney as Principal Accelerator, Establishes SMB Fractional CFO & Accounting Practice in Albuquerque NM

CARDIFF BY THE SEA, Calif., Aug. 8, 2025 /PRNewswire/ -- Dark Horse CPAs, a top national accounting and tax firm serving small businesses and...

Lingerie Fighting Championships Up-lists to OTCID Following Successful UK Events

LAS VEGAS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Lingerie Fighting Championships, Inc. (“LFC”) (OTC Pink:BOTY) announced today that they have up-listed to the newly created OTCID market. In order to do so they had to meet all criteria including be fully SEC reporting, be in good standing with state and federal regulators, retain a recognized transfer agent and file a Company Verified Profile and Management Certification with the OTC.

Triple-Negative Breast Cancer Market Gearing Up for Impressive Growth at a CAGR of 4.7% During the Forecast Period (2025-2034) | DelveInsight

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved...

Triple-Negative Breast Cancer Market Gearing Up for Impressive Growth at a CAGR of 4.7% During the Forecast Period (2025-2034) | DelveInsight

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved...

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

Llusern Scientific Announces Key Appointments to Strengthen its Executive Team

CTO, CMO and CFO appointments to advance the commercial launch of its precision point-of-care diagnostic Lodestar DX for UTIs worldwide 
CTO, CMO and CFO appointments to advance the commercial launch of its precision point-of-care diagnostic Lodestar DX for UTIs worldwide

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight

The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on...

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight

The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on...

Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors

Cardiff, United Kingdom – 15 July 2025 – Draig Therapeutics (“Draig”), a clinical-stage company aiming to transform the treatment of neuropsychiatric diseases, today announces the appointment of Douglas E. Williams, Ph.D. as independent Chair of its Board of Directors. He takes over from Ruth McKernan, who retains her role on the Board as a Director and Interim Chief Executive Officer (CEO).

Heavy Duty: Royal Mint Unveils Coin Celebrating Iron Maiden’s 50th Anniversary

CARDIFF, Wales, July 7, 2025 /PRNewswire/ -- The Royal Mint has today unveiled an eye-catching commemorative coin celebrating 50 years of Iron Maiden. The East...

Heavy Duty: Royal Mint Unveils Coin Celebrating Iron Maiden’s 50th Anniversary

CARDIFF, Wales, July 7, 2025 /CNW/ -- The Royal Mint has today unveiled an eye-catching commemorative coin celebrating 50 years of Iron Maiden. The East...

Heavy Duty: Royal Mint Unveils Coin Celebrating Iron Maiden’s 50th Anniversary

CARDIFF, Wales, July 8, 2025 /PRNewswire/ -- The Royal Mint has today unveiled an eye-catching commemorative coin celebrating 50 years of Iron Maiden. The East...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCardiff

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers